Enjaymo 1100 MG in 22 ML Injection

RxCUI: 2591425
RxNorm name: Enjaymo 1100 MG in 22 ML Injection
Display name: Enjaymo 1100 MG in 22 ML Injection
Full name: Enjaymo 1100 MG in 22 ML Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:51

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761164	Enjaymo	sutimlimab-jome	351(a)	Rx	2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Enjaymo	SUTIMLIMAB-JOME	Recordati Rare Diseases, Inc.	0a25363a-7781-d9f8-cb1c-be22987bf03b	2026-03-02	Warnings, Adverse reactions	Exact identifier rxcui: 2591425

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
281cf1d4-6296-4416-858e-9bff46d01b71	Enjaymo 1100 MG in 22 ML Injection [PSN] · 22 ML sutimlimab-jome 50 MG/ML Injection [Enjaymo] [SBD] · 22 ML Enjaymo 50 MG/ML Injection [SY] · Enjaymo 1100 MG per 22 ML Injection [SY]	4	10	These highlights do not include all the information needed to use ENJAYMO safely and effectively. See full prescribing information for ENJAYMO. ENJAYMO ® (sutimlimab-jome) injection, for intravenous use Initial U.S. Approval: 2022	20240221
0a25363a-7781-d9f8-cb1c-be22987bf03b	Enjaymo 1100 MG in 22 ML Injection [PSN] · 22 ML sutimlimab-jome 50 MG/ML Injection [Enjaymo] [SBD] · 22 ML Enjaymo 50 MG/ML Injection [SY] · Enjaymo 1100 MG per 22 ML Injection [SY]	4	4	These highlights do not include all the information needed to use ENJAYMO safely and effectively. See full prescribing information for ENJAYMO. ENJAYMO ® (sutimlimab-jome) injection, for intravenous use Initial U.S. Approval: 2022	20260302